These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34855729)

  • 1. The next phase in Aotearoa New Zealand's COVID-19 response: a tight suppression strategy may be the best option.
    Baker MG; Kvalsvig A; Crengle S; Harwood M; Tukuitonga C; Betty B; Bonning J; Wilson N
    N Z Med J; 2021 Nov; 134(1546):8-16. PubMed ID: 34855729
    [No Abstract]   [Full Text] [Related]  

  • 2. New Zealand's science-led response to the SARS-CoV-2 pandemic.
    Geoghegan JL; Moreland NJ; Le Gros G; Ussher JE
    Nat Immunol; 2021 Mar; 22(3):262-263. PubMed ID: 33627881
    [No Abstract]   [Full Text] [Related]  

  • 3. [New Zealand's COVID-19 Elimination Strategy - Is it Working?].
    Murdoch DR
    Laeknabladid; 2020 Sep; 106(9):393. PubMed ID: 32902396
    [No Abstract]   [Full Text] [Related]  

  • 4. Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases.
    Baker MG; Wilson N; Blakely T
    BMJ; 2020 Dec; 371():m4907. PubMed ID: 33561814
    [No Abstract]   [Full Text] [Related]  

  • 5. Covid-19 eradication: stopping transmission between countries.
    Palmer BS
    BMJ; 2021 Jun; 373():n1425. PubMed ID: 34099495
    [No Abstract]   [Full Text] [Related]  

  • 6. Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
    Carlton LH; Chen T; Whitcombe AL; McGregor R; Scheurich G; Sheen CR; Dickson JM; Bullen C; Chiang A; Exeter DJ; Paynter J; Baker MG; Charlewood R; Moreland NJ
    Epidemiol Infect; 2021 Jul; 149():e173. PubMed ID: 34668464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 outbreaks in Aotearoa New Zealand: urgent action is required to address systematic causes and consequences of border failures.
    Kvalsvig A; Summers J; Gray L; Telfar-Barnard L; Baker MG
    N Z Med J; 2020 Dec; 133(1527):8-14. PubMed ID: 33332324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Compensation and COVID-19 Vaccines.
    Trogen B; Caplan A
    Ann Intern Med; 2021 Jun; 174(6):858-859. PubMed ID: 33646837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'We felt we had beaten it': New Zealand's race to eliminate the coronavirus again.
    Lewis D
    Nature; 2020 Aug; 584(7821):336. PubMed ID: 32796928
    [No Abstract]   [Full Text] [Related]  

  • 10. Guest Editorial: General practice and COVID-19: the journey to get vaccination experts involved.
    Murton S
    J Prim Health Care; 2021 Sep; 13(3):198-200. PubMed ID: 34588101
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19, 20, 21: lessons from New Zealand's 2020 response for 2021 and beyond.
    Bloomfield A
    N Z Med J; 2021 Feb; 134(1529):7-9. PubMed ID: 33582703
    [No Abstract]   [Full Text] [Related]  

  • 12. New Zealand's covid-19 policy switch will harm vulnerable people.
    van Schalkwyk JM
    BMJ; 2021 Nov; 375():n2738. PubMed ID: 34764138
    [No Abstract]   [Full Text] [Related]  

  • 13. The COVID-19 exit strategy-why we need to aim low.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2021 Mar; 21(3):297. PubMed ID: 33581748
    [No Abstract]   [Full Text] [Related]  

  • 14. New Zealand's elimination strategy for the COVID-19 pandemic and what is required to make it work.
    Baker M; Kvalsvig A; Verrall AJ; Telfar-Barnard L; Wilson N
    N Z Med J; 2020 Apr; 133(1512):10-14. PubMed ID: 32242173
    [No Abstract]   [Full Text] [Related]  

  • 15. Overview of the COVID-19 Pandemic in Japan: Public Health Perspectives in the first half of 2020.
    Suzuki Y
    Keio J Med; 2021 Dec; 70(4):73-81. PubMed ID: 34602536
    [No Abstract]   [Full Text] [Related]  

  • 16. Should the UK vaccinate children and adolescents against covid-19?
    Saxena S; Skirrow H; Wighton K
    BMJ; 2021 Jul; 374():n1866. PubMed ID: 34301635
    [No Abstract]   [Full Text] [Related]  

  • 17. Schools: still a gaping hole in the English covid strategy.
    Pagel C; Squires A
    BMJ; 2021 Dec; 375():n3149. PubMed ID: 34949597
    [No Abstract]   [Full Text] [Related]  

  • 18. Moving Forward Together.
    Kennedy MS
    Am J Nurs; 2021 Jun; 121(6):7. PubMed ID: 34009142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Now? Health Challenges for 2021.
    Flaskerud JH
    Issues Ment Health Nurs; 2021 Mar; 42(3):299-303. PubMed ID: 33493083
    [No Abstract]   [Full Text] [Related]  

  • 20. Will access to COVID-19 vaccine in Aotearoa be equitable for priority populations?
    Whitehead J; Scott N; Carr PA; Lawrenson R
    N Z Med J; 2021 May; 134(1535):25-35. PubMed ID: 34012138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.